CARDIOVASCULAR EVENTS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB

EHA Library, Anastasia Bykova, 216326

DISCONTINUATION OF TYROSINE KINASE INHIBITORS IN PORTUGUESE CML PATIENTS: A SINGLE INSTITUTE EXPERIENCE

EHA Library, Nuno Cerveira, 216327

THE HIGHER THE DOSE OF DASATINIB, THE LOWER THE MOLECULAR RESPONSES AS WELL AS THE GREATER THE DOSE-LIMITING TOXICITIES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Jangik Lee, 216328

MYELOID-DERIVED SUPPRESSOR CELLS IN CHRONIC MYELOID LEUKEMIA

EHA Library, Ari Ahn, 216329

MORE THAN 10-YEARS SURVIVORS WITH CHRONIC MYELOID LEUKEMIA WITHOUT ANY MOLECULAR RESPONSE - REAL LIFE EVIDENCE FROM A SINGLE INSTITUTION

EHA Library, Gueorgui Balatzenko, 216330

EARLY AND SUSTAINED DEEP MOLECULAR RESPONSE OF NILOTINIB AS A FRONTLINE THERAPY IN HIGH SOKAL RISK CML PATIENTS

EHA Library, Uzma Zaidi, 216331

DEVELOPMENT OF SAMPLE PREPARATION PROCEDURE FOR TESTING SPECIMENS WITH HIGH WHITE BLOOD CELL COUNTS FOR XPERT® BCR-ABL ULTRA¥

EHA Library, Gwo-Jen Day, 216332

CHRONIC MYELOID LEUKEMIA WITH ISOLATED THROMBOCYTOSIS WITHOUT SIGNIFICANT LEUKOCYTOSIS IS A SUBTYPE OF CHRONIC MYELOID LEUKEMIA WITH DISTINCT DISEASE CHARACTERISTICS

EHA Library, Yuka Sugimoto, 216333

IMPACT OF BCR-ABL TYROSINE KINASE INHIBITORS ON THE SURVIVAL AND FUNCTIONS OF ENDOTHELIAL CELLS

EHA Library, Hélène Haguet, 216334

LATE MYOCARDIAL TOXICITY IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS ON LONG-TERM TYROSINE KINASE INHIBITOR (TKI) THERAPY

EHA Library, Leanne Genge, 216335

COMORBIDITY INDEX RELATED OUTCOME IN CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Cojbasic Irena, 216336

REAL-WORD DATA FROM LONG TERM FOLLOW-UP OF IMATINIB INITIALLY TREATED CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Cojbasic Irena, 216337

A STUDY TO IDENTIFY THE POPULATION VARIATION IN THE RESPONSE AND THE SIDE EFFECT PROFILE IN CHRONIC MYELOID LEUKEMIA - A NATIONAL EXPERIENCE FROM SRI LANKA

EHA Library, Ovini GAMAGE, 216338

THE SIGNIFICANCE OF VERY EARLY MOLECULAR RESPONSE WITH FRONTLINE DASATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS AS A STRONG PREDICTOR OF LONG-TERM OUTCOME: FINAL ANALYSIS OF PCR-DEPTH STUDY

EHA Library, Won Sik Lee, 216339

NILOTINIB IN 161 PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE AFTER IMATINIB RESISTANCE OR INTOLERANCE: “LA RAZA” NATIONAL MEDICAL CENTER EXPERIENCE

EHA Library, Manuel Ayala, 216340

INTOLERANCES AND HOSPITALIZATIONS AFTER 1, 3 AND 5 YEARS OF TKI THERAPY IN SIMPLICITY, A STUDY OF CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA PATIENTS IN ROUTINE CLINICAL PRACTICE

EHA Library, Michael Mauro, 216341

RESULTS OF GENERIC IMATINIB TREATMENT IN SOKAL INTERMEDIATE & HIGH RISK CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS IN RESOURCE-CONSTRAINED SETTING: A SINGLE-CENTER EXPERIENCE FROM NORTH INDIA

EHA Library, Uttam Kumar Nath, 216342

QUALITY OF LIFE IN CHRONIC MYELOID LEUKEMIA PATIENTS RECEIVING A TYROSINE KINASE INHIBITOR

EHA Library, Eren Gunduz, 216344

THE EVALUATION OF THE TOTAL ANTIOXIDANT CAPACITY IN RELATION TO THE TREATMENT WITH TYROSIN-KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA

EHA Library, Mihnea-Alexandru Găman, 216345

HIGH DIVERSITY IN THE SEQUENTIAL TREATMENT WITH TKI’S OF CML. A LONG-TERM, REAL LIFE ANALYSIS OF THE SPANISH REGISTRY OF CML (RELMC)

EHA Library, Luis Felipe CASADO MONTERO, 216346

SOMATIC MUTATIONS IN PATIENTS WITH CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE, MYELODYSPLASTIC SYNDROME AND RELATED MYELOID NEOPLASMS: A PRELIMINARY STUDY WITH A NORTHEASTERN POPULATION IN BRAZIL

EHA Library, Luciene Oliveira, 216347

THE HYPERMETHYLATION PROFILE OF APOPTOTIC GENES IN MYELODYSPLASTIC SYNDROMES

EHA Library, Farhad ZAKER, 216348

THE ANALYSIS OF EXPRESSION OF FOXP3 MOLECULE’S ISOFORMS BY REGULATORY Т CELLS IN PERIPHERAL BLOOD IN MYELODYSPLASTIC SYNDROME PATIENTS

EHA Library, Galina Dudina, 216349

GENE EXPRESSION AND EPIGENETIC PROFILING SEPARATES CASES WITH DIC(1;7)(Q10;P10) FROM T-MDS/AML

EHA Library, Anair Graciela Lema Fernandez, 216350

TARGET NEXT GENERATION SEQUENCING FOR SOMATIC MUTATION SCREENING IN PATIENTS WITH A LOWER-RISK MDS TREATED WITH THE IRON-CHELATOR DEFERASIROX

EHA Library, Emiliano Fabiani, 216351

VARIATION IN THE LEVEL OF AKT1 IN LYSATES OF BONE MARROW CELLS IN MYELODYSPLASTIC SYNDROMES

EHA Library, Natallia Klimkovich, 216352

TREG LEVELS IN BONE MARROW OF LOW RISK MDS PATIENTS CORRELATE WITH PREFERENTIAL EXPANSION OF CYTOTOXIC T CELLS IN BONE MARROW AND A MORE FAVOURABLE PROGNOSIS.

EHA Library, Stefania Leone, 216353

A SINGLE CENTRE EXPERIENCE OF RESPONSE RATES TO AZACITIDINE FOR MDS, AML AND CMML IN RELATION TO CYTOGENETICS RISK AND PERFORMANCE STATUS

EHA Library, Vidhya Murthy, 216354

CHILDHOOD SECONDARY MYELODYSPLASTIC SYNDROME – CASE REPORT OF A RARE DIAGNOSIS

EHA Library, Medeiros Julia, 216355

THE HIDDEN IMPACT OF PATIENT GENERAL CONDITION ON THE OVERALL SURVIVAL OF MYELODYSPLASTIC SYNDROMES AND RELATED DISEASES (CHRONIC MYELOMONOCYTIC LEUKEMIA AND ACUTE MYELOID LEUKEMIA)

EHA Library, Paola González Carmona, 216356

CHRONIC MYELOMONOCYTIC LEUKEMIA AND AUTOIMMUNE DISORDERS

EHA Library, Gustavo Alberto PINTO SOLANO, 216357

NEXT GENERATION SEQUENCING IN PREDICTING OUTCOME IN MDS- DAWN OF NEW ERA IN PAKISTAN

EHA Library, Nida Anwar, 216358

ACCESS TO DIAGNOSTIC AND THERAPEUTIC TOOLS FOR MYELODYSPLASTIC SYNDROMES IN GENERAL PRACTICE: SURVEY AMONG LATIN-AMERICAN HEMATOLOGISTS

EHA Library, Renee Crisp, 216359

DEVELOPING A CORE OUTCOME SET FOR MYELODYSPLASTIC SYNDROMES – THE MDS-RIGHT HEALTH PROFESSIONAL DELPHI SURVEY

EHA Library, Igor Stojkov, 216360

DEPLETION OF PROGENITORS B CELLS IN CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Gustavo Alberto PINTO SOLANO, 216361

ASSEMENT OF TRANSFUSION FREQUENCY AS A MORTALITY INDICATOR IN MYELODYSPLASTIC SYNDROMES. A SINGLE CENTER DATA.

EHA Library, Sonia Cismas, 216362

THE PREDICTIVE VALUE OF FERRITIN, FOLIC ACID AND VITAMIN B12 AS BIOMARKERS FOR THE DEVELOPMENT OF LEUKEMIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES. A PILOT STUDY

EHA Library, Diana Lighezan, 216363

STUDY ON QUALITY OF THE TRANSFUSION PROCESS IN OUTPATIENT CARE IN A TERTIARY HOSPITAL

EHA Library, Borja CIDONCHA MORCILLO, 216364

NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET COUNT AS PROGNOSTIC INDEX IN MYELODYSPLASTIC SYNDROME

EHA Library, Inga MANDAC ROGULJ, 216366

CHARACTERISTICS AND SURVIVAL OF DIABETIC AND NON-DIABETIC PATIENTS WITH MYELODYSPLATIC SYNDROMES.

EHA Library, Yakir Moshe, 216367

FLOW CYTOMETRIC CHARACTERIZATION OF THE CD4 AND CD8 T CELL IN MDS – IS IT CLINICALLY RELEVANT?

EHA Library, Aisha arshad, 216368

CLINICAL IMPLICATION OF SERUM FERRITIN LEVEL AT DIAGNOSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES.

EHA Library, Masayuki SHISEKI, 216369

MIR-16 IS ASSOCIATED WITH VEGF UPREGULATION IN HIGH-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Yanbo Nie, 216370

ASIA-INCLUSIVE CLINICAL DEVELOPMENT OF PEVONEDISTAT IN COMBINATION WITH AZACITIDINE IN HIGHER RISK MYELODYSPLASTIC SYNDROMES, CHRONIC MYELOMONOCYTIC LEUKEMIA, OR LOW-BLAST ACUTE MYELOID LEUKEMIA

EHA Library, Xiaofei Zhou, 216371

UNUSUAL FAVOURABLE CLINICAL COURSE IN A PATIENT WITH LOW-RISK MYELODYSPLASTIC SYNDROME WITH DEL (5Q) AND ACQUIRED TP53 MUTATION: CLINICAL, BIOLOGICAL AND MOLECULAR SEQUENTIAL STUDY

EHA Library, Carlo Finelli, 216372

HEALTH IMPACT OF THE 5-AZACYTIDINE ADMINISTRATION IN THE DOMICILIARY CARE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Carolina Alarcón-Payer, 216373

EVALUATION OF THE EFFICACY OF LENALIDOMIDE IN PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS) WHO ARE PARTIALLY RESISTANT TO HYPOMETHYLATING THERAPY

EHA Library, Galina Dudina, 216374

IS MDS REALLY TREATABLE? EXPERIENCE FROM PAKISTAN

EHA Library, Nida Anwar, 216375

EPIDEMIOLOGICAL, CLINICAL AND GENETIC CHARACTERIZATION OF APLASTIC ANEMIA PATIENTS IN PAKISTAN

EHA Library, Zaineb Akram, 216376

HOW USEFUL IS CD14 AND CD64 FOR GATING MONOCYTES IN FLOW CYTOMETRIC STUDY FOR PROXIMAL NOCTURNAL HEMOGLOBINURIA?

EHA Library, Woo-Jae Kwoun, 216377

AN UNUSUAL CASE OF PURE RED CELL APLASIA

EHA Library, Moon Ley Tung, 216378

DISTINCT DYNAMICS OF PNH CLONE AND HEMOLYTIC MANIFESTATIONS ACCORDING TO BASELINE CLONE SIZE IN PATIENTS WITH APLASTIC ANEMIA/PNH AFTER IMMUNOSUPPRESSIVE TREATMENT: PROSPECTIVE OBSERVATIONAL STUDY

EHA Library, Sung-Soo Park, 216379

HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN ADULTS - A RETROSPECTIVE ANALYSIS FROM A SINGLE INSTITUTION

EHA Library, Maciej Machaczka, 216380

ELTROMBOPAG FOR THE TREATMENT OF APLASTIC ANEMIA – CROATIAN EXPERIENCE

EHA Library, Drazen Pulanic, 216381

BREAKTHROUGH HEMOLYSIS AND THROMBOEMBOLISM CONTROLLED BY ECULIZUMAB DURING PREGNANCY IN PAROXYSMAL NOCTURAL HEMOGLOBINURIA (PNH): A SINGLE INSTITUTION EXPERIENCE

EHA Library, Chiara FRAIRIA, 216382

FOUR CASES OF FANCONI ANEMIA WITH VARIABLE ABNORMALITIES

EHA Library, Emine TURKKAN, 216383

PIGA MUTATIONS AS A PREDICTORS OF TREATMENT RESPONSE IN PNH

EHA Library, Hee Sue Park, 216384

CHRONIC PRIMARY NEUTROPENIA IN ADULTS. A MONOCENTRIC UNIVERSITY HOSPITAL COHORT STUDY

EHA Library, Linet Njue, 216385

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN CHILDHOOD AND ADOLESCENCE- A 5-YEAR RETROSPECTIVE ANALYSIS FROM A SINGLE TERTIARY CARE CENTER FROM NORTH INDIA.

EHA Library, Rohan Halder, 216386

CLINICAL OUTCOMES IN ADULT PATIENTS WITH APLASTIC ANEMIA: A SINGLE INSTITUTION EXPERIENCE.

EHA Library, Yavor Petrov, 216387

ELTROMBOPAG’S ADDITIVE VALUE IN THE THERAPY OF PEDIATRIC ACQUIRED APLASTIC ANEMIA: A SINGLE INSTITUTION EXPERIENCE

EHA Library, Maria Filippidou, 216388

BEST PRACTICE GUIDANCE FOR NURSES MANAGING PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA ACROSS THE LIFE SPECTRUM

EHA Library, Louise Arnold, 216389

A COMPARISON OF THE ACCURACY IN DETECTING MINOR PNH CLONES IN PATIENTS WITH BONE MARROW FAILURE BETWEEN TWO HIGH-SENSITIVITY FLOW CYTOMETRY ASSAYS: CLSI AND OPTIMA

EHA Library, Kohei Hosokawa, 216390

BONE MARROW FINDINGS IN COLLAGEN VASCULAR DISEASES ASSOCIATED WITH CYTOPENIAS

EHA Library, Doaa elshamy, 216391

FEASIBILITY AND EFFICACY OF COMBINED TREATMENT WITH ELTROMBOPAG AND DEFERASIROX IN PATIENTS AFFECTED BY APLASTIC ANEMIA

EHA Library, Daniela Cilloni, 216392

A RARE CAUSE OF ANEMIA: GHOSAL TYPE HEMATO-DIAPHYSEAL DYSPLASIA

EHA Library, Begum Koc, 216393

CLINICOHEMATOLOGICAL AND CYTOGENETIC PROFILE OF APLASTIC ANEMIA IN PAKISTAN

EHA Library, Nida Anwar, 216394

HUMAN MONOCLONAL IGG DERIVED FROM PATIENTS WITH MULTIPLE MYELOMA ARE ABLE TO PENETRATE LIVING NEOPLASTIC CELLS AND EXHIBIT INTRACELLULAR BIOLOGICAL FUNCTIONS

EHA Library, Evangelos Terpos, 216395

PDCD1, PDL1 AND CTLA4 POLYMORPHISMS ASSOCIATED WITH THE SUSCEPTIBILITY TO AND CLINICAL FEATURES OF MULTIPLE MYELOMA.

EHA Library, Tetsuhiro Kasamatsu, 216396

CIRCULATING EXOSOMAL LONG NON-CODING RNA PRINS – FIRST FINDINGS IN MONOCLONAL GAMMOPATHIES

EHA Library, Dávid Vrábel, 216397

PDGFR-Β AND CXCR4 IN MULTIPLE MYELOMA DISEASE STAGES: PRELIMINARY RESULTS

EHA Library, Leonor Correia, 216398

THE NOVEL TRANSLOCATION OF T(1;21) IN MULTIPLE MYELOMA WITH COMPLEX KARYOTYPE

EHA Library, Mufide OKAY, 216399

ANALYZING BONE AND EXTRAMEDULLARY PLASMACYTOMA SUBSTRATES IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Maiia Soloveva, 216400

INTRODUCTION OF A EUROPEAN QUALITY ASSESSMENT SCHEME FOR GENETIC TESTING IN MYELOMA: PROGRESS AND UPDATE.

EHA Library, Polly Talley, 216401

RAMAN SPECTROSCOPY IS ABLE TO DISCRIMINATE BETWEEN CD138-/CD138+ PLASMA CELLS OF MULTIPLE MYELOMA PATIENTS.

EHA Library, Alessandro Allegra, 216402

NOVEL THERAPEUTICS FOR MULTIPLE MYELOMA TESTED IN A 3D BONE MARROW MODEL

EHA Library, Maaike Braham, 216403

CIRCULATING TUMOR DNA ANALYSIS OF KRAS, NRAS AND BRAF MUTATIONS USING MASS SPECTROMETRY IN MULTIPLE MYELOMA PATIENTS

EHA Library, Liang-Tsai Hsiao, 216405

THE MOLECULAR SIGNATURES OF HIGH RISK MULTIPLE MYELOMA IN THAI POPULATION

EHA Library, Parin Kamseng, 216406

TARGETING SIGLEC-7: A NOVEL IMMUNOTHERAPEUTIC APPROACH TO POTENTIATE THE CYTOTOXIC FUNCTIONS OF NATURAL KILLER CELLS AGAINST MULTIPLE MYELOMA

EHA Library, John Daly, 216407

STUDY OF MULTIPLE MYELOMA CHROMOSOMAL ABNORMALITIES BY MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION: CORRELATIONS WITH FLUORESCENCE IN SITU HYBRIDIZATION

EHA Library, Flavia Carbone, 216408

ALTERED MICRORNA EXPRESSION PROFILE IN THE PERIPHERAL LYMPHOMONOCYTES OF MULTIPLE MYELOMA PATIENTS WITH BISPHOSPHONATE-INDUCED OSTEONECROSIS OF THE JAW.

EHA Library, Vanessa Innao, 216409

A ROLE OF LIGHT AS POTENTIAL BIOMARKER FOR PROGRESSION OF SMOLDERING TO SYMPTOMATIC MULTIPLE MYELOMA

EHA Library, Rita Rizzi, 216410

DIFFERENTIAL MIRNOME EXPRESSION PROFILE IN NON TUMOR LYMPHOMONOCYTES OF THE PERIPHERAL COMPARTMENT OF MGUS SUBJECTS

EHA Library, Oriana Francesca Bianco, 216411

DETECTION OF MYD88 L265P MUTATION BY DIGITAL PCR IN PERIPHERAL BLOOD SAMPLES FROM IGM MONOCLONAL GAMMOPATHY PATIENTS

EHA Library, Nieves Garcia-Gisbert, 216412

IMPACT OF THE EXPRESSION OF LRP GENE ON THE SENSITIVITY OF TUMOR PLASMA CELLS TO BORTEZOMIB IN VIVO AND IN VITRO

EHA Library, Yulia Chernykh, 216413

EFFECT OF AUTOLOGOUS STEM CELLS TRANSPLANTATION OF PATIENTS WITH MULTIPLE MYELOMA ON THE CALORIMETRIC MARKERS OF THE SERUM PROTEOME. CORRELATION WITH THE IMMUNOLOGICAL MARKERS

EHA Library, Lidia Gartcheva, 216414

PODOCYTURIA IN MULTIPLE MYELOMA PATIENTS HAS A TENDENCY TO INCREASE WİTH TREATMENT

EHA Library, Emel Gurkan, 216415

RELATIONSHIP OF MOLECULAR PECULIARITIES WITH CYTOGENETIC ABERRATIONS IN MULTIPLE MYELOMA

EHA Library, Elena Nazarova, 216416

ACTIVIN A: A NOVEL URINARY BIOMARKER REFLECTING EARLY RENAL IMPAIRMENT IN MULTIPLE MYELOMA

EHA Library, Hirono Iriuchishima, 216417

BONE MARROW MESENCHYMAL STROMAL CELLS FROM HEALTHY DONORS SECRETE ANTI-ANGIOGENIC EXTRACELLULAR VESICLES AS WELL AS SOLUBLE FACTORS HAVING GROWTH INHIBITORY EFFECT IN MULTIPLE MYELOMA

EHA Library, Tomohiro UMEZU, 216418

MOGROL REPRESENTS A NOVEL ANTI-MYELOMA AGENT VIA ERK AND NF-ΚB INHIBITION

EHA Library, Shidai Mu, 216419

MYELOMA CELL DEATH INDUCED BY ZEBULARINE LEADS TO CMYC DOWNREGULATION AND IS DECREASED BY CYTIDINE DEAMINASE OVEREXPRESSION.

EHA Library, Patryk Krzeminski, 216420

FEATURES OF STROMAL BONE MARROW MICROENVIRONMENT IN PATIENTS WITH MULTIPLE MYELOMA WITH INEFFECTIVE TRANSPLANTATION OF PERIPHERAL HEMATOPOIETIC STEM CELLS

EHA Library, Natalya Semenova, 216422

HIGH-RISK YOUNG MULTIPLE MYELOMA PATIENTS TREATED UP-FRONT WITH LENALIDOMIDE: IMPACT OF KIR 3DL1-EDU AND KIR HAPLOTYPES ON CLINICAL OUTCOME

EHA Library, Fabrizio Puglisi, 216423

ASSOCIATION OF HLA-SPECIFICITIES OF CLASSES I, II WITH IMMUNOCHEMICAL VARIANTS OF MULTIPLE MYELOMA

EHA Library, Elena Poponina, 216424

RECONSIDERING JAK2 IN AN INTER-TUMOUR HETEROGENEITY OF MULTIPLE MYELOMA

EHA Library, Teerapong Siriboonpiputtana, 216425

MOLECULAR CYTOGENETIC ANALYSIS IN MULTIPLE MYELOMA/PLASMA CELL LEUKEMIA PATIENTS WITH CIRCULATING PLASMA CELLS

EHA Library, Jana Balcarkova, 216426

THE INVOLVEMENT OF MESANGIOGENIC PROGENITOR CELLS IN MULTIPLE MYELOMA PATHOGENESIS

EHA Library, Claudia Pia Schifone, 216427

MYELOID AND LYMPHOID DENDRITIC CELLS IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE - POSSIBLE LINK WITH DISEASE PROGRESSION

EHA Library, Ewelina Grywalska, 216428

QUANTIFICATION AND CHARACTERIZATION OF BONE MARROW MESENCHYMAL STROMAL CELLS IN MONOCLONAL GAMMOPATHIES

EHA Library, João Barradas, 216429